BioNTech SE
BNTX
$99.47
$2.012.06%
Weiss Ratings | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | C- | |||
Rating Factors | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Very Weak | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.93 | |||
Price History | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -13.33% | |||
30-Day Total Return | -17.71% | |||
60-Day Total Return | -17.37% | |||
90-Day Total Return | -12.05% | |||
Year to Date Total Return | -13.73% | |||
1-Year Total Return | 7.06% | |||
2-Year Total Return | -23.71% | |||
3-Year Total Return | -33.89% | |||
5-Year Total Return | 151.09% | |||
52-Week High % Change | -25.88% | |||
52-Week Low % Change | 27.36% | |||
Price | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $131.49 | |||
52-Week Low Price | $76.53 | |||
52-Week Low Price (Date) | Aug 05, 2024 | |||
52-Week High Price (Date) | Sep 17, 2024 | |||
Valuation | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 23.39B | |||
Enterprise Value | 6.28B | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -2.11 | |||
Earnings Per Share Growth | -118.28% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 7.22 | |||
Price/Book (Q) | 1.10 | |||
Enterprise Value/Revenue (TTM) | 1.90 | |||
Price | $99.47 | |||
Enterprise Value/EBITDA (TTM) | -8.49 | |||
Enterprise Value/EBIT | -6.83 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 244.57M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | $1.55 | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | $1.55 | |||
Company Info | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 49 6131 9084 0 | |||
Address | -- | |||
Website | www.biontech.de | |||
Country | Germany | |||
Year Founded | 2008 | |||
Profitability | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -27.82% | |||
Profit Margin | -15.16% | |||
Management Effectiveness | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -2.37% | |||
Return on Equity | -- | |||
Income Statement | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 3.30B | |||
Total Revenue (TTM) | 3.30B | |||
Revenue Per Share | $13.51 | |||
Gross Profit (TTM) | 2.78B | |||
EBITDA (TTM) | -738.86M | |||
EBIT (TTM) | -919.13M | |||
Net Income (TTM) | -500.78M | |||
Net Income Avl. to Common (TTM) | -500.78M | |||
Total Revenue Growth (Q YOY) | 40.44% | |||
Earnings Growth (Q YOY) | 24.59% | |||
EPS Diluted (TTM) | -2.11 | |||
EPS Diluted Growth (Q YOY) | 23.96% | |||
Balance Sheet | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 18.64B | |||
Cash Per Share (Q) | $76.20 | |||
Total Current Assets (Q) | 20.62B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 21.32B | |||
Current Ratio (Q) | 7.329 | |||
Book Value Per Share (Q) | $88.93 | |||
Total Assets (Q) | 24.98B | |||
Total Current Liabilities (Q) | 2.81B | |||
Total Debt (Q) | 271.80M | |||
Total Liabilities (Q) | 3.67B | |||
Total Common Equity (Q) | 21.32B | |||
Cash Flow | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -5.82B | |||
Cash from Financing (TTM) | -55.69M | |||
Net Change in Cash (TTM) | -4.21B | |||
Levered Free Cash Flow (TTM) | 1.21B | |||
Cash from Operations (TTM) | 1.62B | |||